Details of Drug

Drug General Information (ID: D1207)
Drug Name	Oxymetholone
Drug Type	Small molecule
Drug Synonymous	oxymetholone; Anasterone; 434-07-1; HMS3393H15 Click to Show/Hide
Disease Class	3A70: Aplastic anaemia
Therapeutic Class	Androgens/Anabolic Steroids
Structure
Structure	3D Structure		2D Structure
Formula	C21H32O3
InChI	1S/C21H32O3/c1-19-11-13(12-22)18(23)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,22,24H,4-11H2,1-3H3/b13-12-/t14-,15+,16-,17-,19-,20-,21-/m0/s1
InChIKey	ICMWWNHDUZJFDW-DHODBPELSA-N
Canonical SMILES	CC12CCC3C(C1CCC2(C)O)CCC4C3(CC(=CO)C(=O)C4)C
External Link
	Pubchem ID	5281034
	CAS Number	434-07-1
	CHEBI ID	7864
	TTD ID	D0Q6NZ
	INTEDE ID	DR1225

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM006 Pharmacodynamic additive effects BM047 Additive thrombogenic effects BM055 Increased risk of hepatotoxicity BM064 Increased risk of hypoglycemia BM083 Potentiated the pharmacological effects (Unspecific) BM108 Increased risk of hypercalcemia
Relation Graph

Full list of drugs interacting with Oxymetholone
Pharmacodynamic additive effects
	Additive thrombogenic effects					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0261		Carfilzomib	C40H57N5O7	11556711	Major		Inter Info	[5], [6], [7]
D0762		Human C1-esterase inhibitor	NA	NA	Moderate		Inter Info	[119], [120], [121]
D0385		Conestat alfa	NA	NA	Moderate		Inter Info	[119], [149], [120], [121]
	Increased risk of hepatotoxicity					Drug Num: 23
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[1], [2], [3]
D1073		Mipomersen	C230H324N67O122P19S19	118984467	Major		Inter Info	[4]
D0944		Lomitapide	C39H37F6N3O2	9853053	Major		Inter Info	[8]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Major		Inter Info	[9]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[1], [2], [3]
D0357		Clofarabine	C10H11ClFN5O3	119182	Moderate		Inter Info	[17]
D0554		Efavirenz	C14H9ClF3NO2	64139	Moderate		Inter Info	[18], [19]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[5], [7], [20]
D0826		Interferon beta-1a	NA	NA	Moderate		Inter Info	[129], [130], [131], [132]
D0827		Interferon beta-1b	NA	NA	Moderate		Inter Info	[129], [130], [131], [132]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[7], [133]
D1106		Naltrexone	C20H23NO4	5360515	Moderate		Inter Info	[134]
D0113		Asparaginase Erwinia chrysanthemi	NA	NA	Moderate		Inter Info	[135], [136], [137], [5], [7], [138], [139], [140], [141], [142], [143], [144], [145]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Moderate		Inter Info	[146]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[147]
D0232		Calaspargase pegol	NA	NA	Moderate		Inter Info	[135], [136], [137], [5], [7], [138], [139], [140], [141], [142], [143], [144], [145]
D0248		Cannabidiol	C21H30O2	644019	Moderate		Inter Info	[7], [148]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[150]
D1239		Peginterferon beta-1a	NA	NA	Moderate		Inter Info	[129], [130], [131], [132]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[5], [7], [151], [152], [153]
D1234		Pegaspargase	C14H19NO	436058	Moderate		Inter Info	[135], [136], [137], [5], [7], [138], [139], [140], [141], [142], [143], [144], [145]
D1589		Tioguanine	C5H5N5S	2723601	Moderate		Inter Info	[154], [155]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[7], [156]
	Increased risk of hypoglycemia					Drug Num: 21
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0013		Acetohexamide	C15H20N2O4S	1989	Moderate		Inter Info	[10], [11], [12]
D0325		Chlorpropamide	C10H13ClN2O3S	2727	Moderate		Inter Info	[10], [11], [12]
D0728		Glipizide	C21H27N5O4S	3478	Moderate		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [10], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [11], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [12], [111], [112], [113], [114], [115], [116], [117], [118]
D0730		Glyburide	C23H28ClN3O5S	3488	Moderate		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [10], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [11], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [12], [111], [112], [113], [114], [115], [116], [117], [118]
D0807		Insulin aspart (aspart protamine)	C256H381N65O79S6	118984445	Moderate		Inter Info	[28], [83], [100]
D0808		Insulin aspart (aspart)	C256H381N65O79S6	118984445	Moderate		Inter Info	[28], [83], [100]
D0810		Insulin detemir	C267H402N64O76S6	16137271	Moderate		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [122], [32], [33], [10], [34], [35], [36], [37], [38], [40], [41], [42], [44], [45], [46], [47], [48], [49], [50], [52], [54], [55], [56], [57], [58], [59], [60], [61], [62], [64], [67], [69], [70], [71], [74], [75], [77], [78], [79], [81], [123], [83], [124], [125], [88], [126], [127], [94], [96], [97], [98], [100], [102], [104], [106], [107], [12], [111], [112], [113], [128], [114], [115], [117], [118]
D0811		Insulin glargine	C267H404N72O78S6	118984454	Moderate		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [122], [32], [33], [10], [34], [35], [36], [37], [38], [40], [41], [42], [44], [45], [46], [47], [48], [49], [50], [52], [54], [55], [56], [57], [58], [59], [60], [61], [62], [64], [67], [69], [70], [71], [74], [75], [77], [78], [79], [81], [123], [83], [124], [125], [88], [126], [127], [94], [96], [97], [98], [100], [102], [104], [106], [107], [12], [111], [112], [113], [128], [114], [115], [117], [118]
D0812		Insulin glulisine	C258H384N64O78S6	16136701	Moderate		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [122], [32], [33], [10], [34], [35], [36], [37], [38], [40], [41], [42], [44], [45], [46], [47], [48], [49], [50], [52], [54], [55], [56], [57], [58], [59], [60], [61], [62], [64], [67], [69], [70], [71], [74], [75], [77], [78], [79], [81], [123], [83], [124], [125], [88], [126], [127], [94], [96], [97], [98], [100], [102], [104], [106], [107], [12], [111], [112], [113], [128], [114], [115], [117], [118]
D0813		Insulin human	C257H383N65O77S6	118984375	Moderate		Inter Info	[28], [83], [100]
D0814		Insulin human (inhalation, rapid acting)	C257H383N65O77S6	118984375	Moderate		Inter Info	[28], [83], [100]
D0815		Insulin human (isophane)	C257H383N65O77S6	118984375	Moderate		Inter Info	[28], [83], [100]
D0816		Insulin human (regular)	C257H383N65O77S6	118984375	Moderate		Inter Info	[28], [83], [100]
D0817		Insulin human (zinc extended)	C257H383N65O77S6	118984375	Moderate		Inter Info	[28], [83], [100]
D0818		Insulin human (zinc)	C257H383N65O77S6	118984375	Moderate		Inter Info	[28], [83], [100]
D0819		Insulin lispro	C257H389N65O77S6	16132438	Moderate		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [122], [32], [33], [10], [34], [35], [36], [37], [38], [40], [41], [42], [44], [45], [46], [47], [48], [49], [50], [52], [54], [55], [56], [57], [58], [59], [60], [61], [62], [64], [67], [69], [70], [71], [74], [75], [77], [78], [79], [81], [123], [83], [124], [125], [88], [126], [127], [94], [96], [97], [98], [100], [102], [104], [106], [107], [12], [111], [112], [113], [128], [114], [115], [117], [118]
D0820		Insulin lispro (protamine)	C257H389N65O77S6	16132438	Moderate		Inter Info	[28], [83], [100]
D1112		Nateglinide	C19H27NO3	5311309	Moderate		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [10], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [11], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [12], [111], [112], [113], [114], [115], [116], [117], [118]
D1392		Repaglinide	C27H36N2O4	65981	Moderate		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [10], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [11], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [12], [111], [112], [113], [114], [115], [116], [117], [118]
D1601		Tolazamide	C14H21N3O3S	5503	Moderate		Inter Info	[10], [11], [12]
D1603		Tolbutamide	C12H18N2O3S	5505	Moderate		Inter Info	[10], [11], [12]
	Potentiated the pharmacological effects (Unspecific)					Drug Num: 11
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0215		Budesonide	C25H34O6	5281004	Moderate		Inter Info	[13], [14]
D0392		Corticotropin	C207H308N56O58S	16132265	Moderate		Inter Info	[13], [14]
D0671		Fludrocortisone	C21H29FO5	31378	Moderate		Inter Info	[13], [14]
D0773		Hydrocortisone	C21H30O5	5754	Moderate		Inter Info	[13], [14]
D1041		Methylprednisolone	C22H30O5	6741	Moderate		Inter Info	[13], [14]
D0436		Deflazacort	C25H31NO6	189821	Moderate		Inter Info	[13], [14]
D1332		Prednisolone	C21H28O5	5755	Moderate		Inter Info	[13], [14]
D1334		Prednisone	C21H26O5	5865	Moderate		Inter Info	[13], [14]
D1563		Tetracosactide	C136H210N40O31S	16133802	Moderate		Inter Info	[13], [14]
D1628		Triamcinolone	C21H27FO6	31307	Moderate		Inter Info	[13], [14]
D1630		Triamcinolone (ophthalmic)	C21H27FO6	31307	Moderate		Inter Info	[13], [14]
	Increased risk of hypercalcemia					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1753		Calcipotriol (topical)	C27H40O3	5288783	Moderate		Inter Info	[15], [16]
D1754		Calcitriol (topical)	C27H44O3	5280453	Moderate		Inter Info	[15], [16]

References
1	Canadian Pharmacists Association.
2	EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
3	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
4	Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
5	Cerner Multum, Inc. "Australian Product Information.".
6	Product Information. Kyprolis (carfilzomib). Onyx Pharmaceuticals Inc, South San Francisco, CA.
7	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
8	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
9	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
10	Christensen LK, Hansen JM, Kristensen M "Sulphaphenazole-induced hypoglycemic attacks in tolbutamide-treated diabetics." Lancet 2 (1963): 1298-301. [PMID: 14071924]
11	Field JB, Ohta M, Boyle C, Remer A "Potentiation of acetohexamide hypoglycemia by phenylbutazone." N Engl J Med 277 (1967): 889-94. [PMID: 6061822]
12	Turtle JR, Burgess JA "Hypoglycemic action of fenfluramine in diabetes mellitus." Diabetes 22 (1973): 858-67. [PMID: 4749404]
13	Product Information. AndroGel (testosterone). Unimed Pharmaceuticals, Buffalo Grove, IL.
14	Product Information. Oxandrin (oxandrolone). Bio-Tech, Levittown, PA.
15	Product Information. Vectical (calcitriol topical). Galderma Laboratories Inc, Cranbury, NJ.
16	Product Information. Dovonex (calcipotriene). Westwood Squibb Pharmaceutical Corporation, Eatontown, NJ.
17	Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
18	Elsharkawy AM, Schwab U, McCarron B, et al. "Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser." J Clin Virol 58 (2013): 331-3. [PMID: 23763943]
19	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
20	Product Information. Ellence (epirubicin) Pharmacia and Upjohn, Kalamazoo, MI.
21	Abad S, Moachon L, Blanche P, Bavoux F, Sicard D, Salmon-Ceron D "Possible interaction between glicazide, fluconazole and sulfamethoxazole resulting in severe hypoglycaemia." Br J Clin Pharmacol 52 (2001): 456-7. [PMID: 11678792]
22	Ahmad S "Drug interaction induces hypoglycemia." J Fam Pract 40 (1995): 540-1. [PMID: 7775905]
23	Ahmad S "Gemfibrozil: interaction with glyburide." South Med J 84 (1991): 102. [PMID: 1898783]
24	Aleyassine H, Gardiner RJ "Dual action of antidepressant drugs (MAO inhibitors) on insulin release." Endocrinology 96 (1975): 702-10. [PMID: 1090438]
25	Aleyassine H, Lee SH "Inhibition of insulin release by substrates and inhibitors of monoamine oxidase." Am J Physiol 222 (1972): 565-9. [PMID: 5022664]
26	Almirall J, Montoliu J, Torras A, Revert L "Propoxyphene-induced hypoglycemia in a patient with chronic renal failure." Nephron 53 (1989): 273-5. [PMID: 2797348]
27	Arauz-Pacheco C, Ramirez LC, Rios JM, Raskin P "Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy." Am J Med 89 (1990): 811-3. [PMID: 2123605]
28	Asplund K, Wiholm BE, Lithner F "Glibenclamide-associated hypoglycaemia: a report on 57 cases." Diabetologia 24 (1983): 412-7. [PMID: 6411511]
29	Baciewicz AM, Swafford WB Jr "Hypoglycemia induced by the interaction of chlorpropamide and co-trimoxazole." Drug Intell Clin Pharm 18 (1984): 309-10. [PMID: 6609055]
30	Barbato M "Another problem with Kinidin." Med J Aust 141 (1984): 685. [PMID: 6436654]
31	Baron SH "Salicylates as hypoglycemic agents." Diabetes Care 5 (1982): 64-71. [PMID: 6754304]
32	Cacoub P, Deray G, Baumelou A, Grimaldi A, Soubrie C, Jacobs C "Disopyramide-induced hypoglycemia: case report and review of the literature." Fundam Clin Pharmacol 3 (1989): 527-35. [PMID: 2691378]
33	Cattaneo AG, Caviezel F, Pozza G "Pharmacological interaction between tolbutamide and acetylsalicylic acid: study on insulin secretion in man." Int J Clin Pharmacol Ther Toxicol 28 (1990): 229-34. [PMID: 2198232]
34	Cooper AJ, Ashcroft G "Potentiation of insulin hypoglycaemia by M.A.O.I. antidepressant drugs." Lancet 1 (1966): 407-9. [PMID: 4159787]
35	Croxson MS, Shaw DW, Henley PG, Gabriel HDLL "Disopyramide-induced hypoglycaemia and increased serum insulin." N Z Med J July (1987): 407-8. [PMID: 3330586]
36	Darcy PF, Griffin JP "Interactions with drugs used in the treatment of depressive illness." Adverse Drug React Toxicol Rev 14 (1995): 211-31. [PMID: 8845455]
37	Daubresse JC, Daigneux D, Bruwier M, Luyckx A, Lefebvre PJ "Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents." Br J Clin Pharmacol 7 (1979): 599-603. [PMID: 380614]
38	Daubresse JC, Luyckx AS, Lefebvre PJ "Potentiation of hypoglycemic effect of sulfonylureas by clofibrate." N Engl J Med 294 (1976): 613. [PMID: 1246250]
39	David DS, Steere AC Jr, Pi-Sunyer XF, Sakai S, Clark SB "Aspirin-induced hypoglycaemia in a patient on haemodialysis." Lancet 2 (1971): 1092-3. [PMID: 4106934]
40	Davis TM, Karbwang J, Looareesuwan S, et al "Comparative effects of quinine and quinidine on glucose metabolism in healthy volunteers." Br J Clin Pharmacol 30 (1990): 397-403. [PMID: 2223418]
41	de Salcedo I, Gorringe AL, Silva JL, Santos JA "Gemfibrozil in a group of diabetics." Proc R Soc Med 69 (1976): 64-70. [PMID: 1019155]
42	Deeg MA, Lipkin EW "Hypoglycemia associated with the use of fluoxetine." West J Med 164 (1996): 262-3. [PMID: 8775944]
43	Diwan PV, Sastry MS, Satyanarayana NV "Potentiation of hypoglycemic response of glibenclamide by piroxicam in rats and humans." Indian J Exp Biol 30 (1992): 317-9. [PMID: 1459600]
44	Feher MD, Amiel S "ACE inhibitors and hypoglycaemia." Lancet 346 (1995): 125-6. [PMID: 7603199]
45	Feldman JM, Chapman B "Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insulin secretion." Diabetologia 11 (1975): 487-94. [PMID: 1107123]
46	Ferrari C, Fressati S, Romussi M, et al. "Effects of short-term clofibrate administration on glucose tolerance and insulin secretion in patients with chemical diabetes or hypertriglyceridemia." Metabolism 26 (1977): 129-39. [PMID: 834147]
47	Ferriere M, Lachkar H, Richard JL, Bringer J, Orsetti A, Mirouze J "Captopril and insulin sensitivity." Ann Intern Med 102 (1985): 134-5. [PMID: 3881067]
48	Fogari R, Zoppi A, Corradi L, Pierangelo L, Mugellini A, Lusardi P "Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertension." Br J Clin Pharmacol 46 (1998): 467-71. [PMID: 9833600]
49	Giugliano D, Ceriello A, Saccomanno F, et al "Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus." J Clin Endocrinol Metab 61 (1985): 160-6. [PMID: 3923028]
50	Goldberg IJ, Brown LK, Rayfield EJ "Disopyramide (norpace)-induced hypoglycemia." Am J Med 69 (1980): 463-6. [PMID: 6998294]
51	Harris EL "Adverse reactions to oral antidiabetic agents." Br Med J 3 (1971): 29-30. [PMID: 5091891]
52	Harrison LC, King-Roach A, Martin FI, Melick RA "The effect of fenfluramine on insulin binding and on basal and insulin-stimulated oxidation of 1-C-glucose by human adipose tissue." Postgrad Med J 51 Suppl 1 (1975): 110-4. [PMID: 1219664]
53	Hartmann D, Korn A, Komjati M, Heinz G, Haefelfinger P, Defoin R, Waldhausl WK "Lack of effect of tenoxicam on dynamic responses to concurrent oral doses of glucose and glibenclamide." Br J Clin Pharmacol 30 (1990): 245-52. [PMID: 2119677]
54	Hayashi S, Horie M, Tsuura Y, Ishida H, Okada Y, Seino Y, Sasayama S "Disopyramide blocks pancreatic ATP-sensitive K+ channels and enhances insulin release." Am J Physiol 265 (1993): c337-42. [PMID: 8368263]
55	Hekimsoy Z, Biberoglu S, Comlekci A, Tarhan O, Mermut C, Biberoglu K "Trimethoprim/sulfamethoxazole-induced hypoglycemia in a malnourished patient with severe infection." Eur J Endocrinol 136 (1997): 3046. [PMID: 9100556]
56	Hellman B "Potentiating effects of drugs on the binding of glibenclamide to pancreatic beta cells." Metabolism 23 (1974): 839-46. [PMID: 4212254]
57	Herings RMC, Deboer A, Stricker BHC, Leufkens HGM, Porsius A "Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme." Lancet 345 (1995): 1195-8. [PMID: 7739305]
58	Hundal RS, Petersen KF, Mayerson AB, et al "Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes." J Clin Invest 109 (2002): 1321-6. [PMID: 12021247]
59	Iida H, Morita T, Suzuki E, Iwasawa K, Toyooka T, Nakajima T "Hypoglycemia induced by interaction between clarithromycin and disopyramide." Jpn Heart J 40 (1999): 91-6. [PMID: 10370402]
60	Johnson J, Dobmeier M "Symptomatic hypoglycemia secondary to a glipizide-trimethoprim/sulfamethoxazole drug interaction." DICP 24 (1990): 250-1. [PMID: 2316232]
61	Johnson JA, Kappel JE, Sharif MN "Hypoglycemia secondary to trimethoprim/sulfamethoxazole administration in a renal transplant patient." Ann Pharmacother 27 (1993): 304-6. [PMID: 8453166]
62	Konttinen A, Kuisma I, Ralli R, Pohjola S, Ojala K "The effect of gemfibrozil on serum lipids in diabetic patients." Ann Clin Res 11 (1979): 240-5. [PMID: 398183]
63	Kradjan WA, Witt DM, Opheim KE, Wood FC "Lack of interaction between glipizide and co-trimoxazole." J Clin Pharmacol 34 (1994): 997-1002. [PMID: 7836551]
64	Kubacka RT, Antla EJ, Juhl RP, Welshman IR "Effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects." Ann Pharmacother 30 (1996): 20-6. [PMID: 8773160]
65	Lozada A, Dujovne CA "Drug interactions with fibric acids." Pharmacol Ther 63 (1994): 163-76. [PMID: 7809177]
66	Lumholtz B, Siersbaek-Nielsen K, Skovsted L, Kampmann J, Hansen JM "Sulfamethizole-induced inhibition of diphenylhydantoin, tolbutamide, and warfarin metabolism." Clin Pharmacol Ther 17 (1975): 731-4. [PMID: 1139863]
67	Morris AD, Newton RW, Boyle DI, et al. "ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes." Diabetes Care 20 (1997): 1363-7. [PMID: 9283780]
68	Morrison PJ, Rogers HJ, Spector RG, Bradbrook ID, John VA "Effect of pirprofen on glibenclamide kinetics and response." Br J Clin Pharmacol 14 (1982): 123-6. [PMID: 6809024]
69	Murakami K, Nambu S, Koh H, Kobayashi M, Shigeta Y "Clofibrate enhances the affinity of insulin receptors in non-insulin dependent diabetes mellitus." Br J Clin Pharmacol 17 (1984): 89-91. [PMID: 6362704]
70	Nakabayashi H, Ito T, Igawa T, Hiraiwa Y, Imamura T, Seta T, Kawato M, Usukura N, Takeda R "Disopyramide induces insulin secretion and plasma glucose diminution: studies using the in situ canine pancreas." Metabolism 38 (1989): 179-83. [PMID: 2643753]
71	Nappi JM, Dhanani S, Lovejoy JR, VanderArk C "Severe hypoglycemia associated with disopyramide." West J Med 138 (1983): 95-7. [PMID: 6404062]
72	Niemi M, Backman JT, Neuvonen M, Laitila J, Neuvonen PJ, Kivisto KT "Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride." Clin Pharmacol Ther 69 (2001): 194-200. [PMID: 11309547]
73	Nikkila EA, Ylikahri R, Huttunen JK "Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia." Proc R Soc Med 69 (1976): 58-63. [PMID: 190608]
74	Paolisso G, Balbi V, Gambardella A, Varricchio G, Tortoriello R, Saccomanno F, Amato L, Varricchio M "Lisinopril administration improves insulin action in aged patients with hypertension." J Hum Hypertens 9 (1995): 541-6. [PMID: 7562882]
75	Pestell RG, Crock PA, Ward GM, Alford FP, Best JD "Fenfluramine increases insulin action in patients with NIDDM." Diabetes Care 12 (1989): 252-8. [PMID: 2495916]
76	Petitpierre B, Perrin L, Rudhardt M, et al "Behaviour of chlorpropamide in renal insufficiency and under the effect of associated drug therapy." Int J Clin Pharmacol 6 (1972): 120-4. [PMID: 4638970]
77	Phillips AF, Matty PJ, Porte PJ, Raye JR "Inhibition of glucose-induced insulin secretion by indomethacin and sodium salicylate in the fetal lamb." Am J Obstet Gynecol 148 (1984): 481-7. [PMID: 6364813]
78	Phillips RE, Looareesuwan S, White NJ, et al "Hypoglycaemia and antimalarial drugs: quinidine and release of insulin." Br Med J 292 (1986): 1319-21. [PMID: 3085830]
79	Pollak PT, Mukherjee SD, Fraser AD "Sertraline-induced hypoglycemia." Ann Pharmacother 35 (2001): 1371-4. [PMID: 11724085]
80	Pond SM, Birkett DJ, Wade DN "Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole." Clin Pharmacol Ther 22 (1977): 573-9. [PMID: 913025]
81	Prince RL, Larkins RG, Alford FP "The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects." Metabolism 30 (1981): 293-8. [PMID: 7010074]
82	Product Information. Amaryl (glimepiride). Hoechst Marion-Roussel Inc, Kansas City, MO.
83	Product Information. Apidra (insulin glulisine). Aventis Pharmaceuticals, Bridgewater, NJ.
84	Product Information. Diabeta (glyburide). Hoechst Marion-Roussel Inc, Kansas City, MO.
85	Product Information. Diabinese (chlorpropamide). Pfizer US Pharmaceuticals, New York, NY.
86	Product Information. Dymelor (acetohexamide) Lilly, Eli and Company, Indianapolis, IN.
87	Product Information. Glucotrol (glipizide). Pfizer US Pharmaceuticals, New York, NY.
88	Product Information. Increlex (mecasermin). Tercica Inc, Brisbane, CA.
89	Product Information. Micronase (glyburide). Pharmacia and Upjohn, Kalamazoo, MI.
90	Product Information. Orinase (tolbutamide) Pharmacia and Upjohn, Kalamazoo, MI.
91	Product Information. Prandin (repaglinide). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
92	Product Information. Starlix (nateglinide) Novartis Pharmaceuticals, East Hanover, NJ.
93	Product Information. Tolinase (tolazamide) Pharmacia and Upjohn, Kalamazoo, MI.
94	Quevedo SF, Krauss DS, Chazan JA, et al "Fasting hypoglycemia secondary to disopyramide therapy." JAMA 245 (1981): 2424. [PMID: 6785461]
95	Ravic M, Johnston A, Turner P "Clinical pharmacological studies of some possible interactions of lornoxicam with other drugs." Postgrad Med J 66 (1990): s30-4. [PMID: 2126624]
96	Richardson T, Foster J, Mawer GE "Enhancement by sodium salicylate of the blood glucose lowering effect of chlorpropamide-drug interaction or summation of similar effects." Br J Clin Pharmacol 22 (1986): 43-8. [PMID: 3527244]
97	Rubin M, Zakheim B, Pitchumoni C "Disopyramide-induced profound hypoglycemia." N Y State J Med July,Aug,S (1983): 1057-8. [PMID: 6579404]
98	Salmela PI, Sotaniemi EA, Viikari J, et al "Fenfluramine therapy in non-insulin-dependent diabetic patients effects on body weight, glucose homeostasis, serum lipoproteins, and antipyrine metabolism." Diabetes Care 4 (1981): 535-40. [PMID: 6751729]
99	Sawka AM, Burgart V, Zimmerman D "Loss of awareness of hypoglycemia temporally associated with selective serotonin reuptake inhibitors." Diabetes Care 24 (2001): 1845-6. [PMID: 11574457]
100	Semel JD, Wortham E, Karl DM "Fasting hypoglycemia associated with disopyramide." Am Heart J 106 (1983): 1160-1. [PMID: 6356848]
101	Shah SJ, Bhandarkar SD, Satoskar RS "Drug interaction between chlorpropamide and non-steroidal anti-flammatory drugs, ibuprofen and phenylbutazone." Int J Clin Pharmacol Ther Toxicol 22 (1984): 470-2. [PMID: 6500764]
102	Sievenpiper JL, Arnason JT, Leiter LA, Vuksan V "Variable effects of American ginseng: a batch of American ginseng (Panax quinquefolius L.) with a depressed ginsenoside profile does not affect postprandial glycemia." Eur J Clin Nutr 57 (2003): 243-8. [PMID: 12571655]
103	Sjoberg S, Wiholm BE, Gunnarsson R, Emilsson H, Thunberg E, Christenson I, Ostman J "Lack of pharmacokinetic interaction between glibenclamide and trimethoprim-sulphamethoxazole." Diabet Med 4 (1987): 245-7. [PMID: 2956028]
104	Slade IH, and Iosefa RN "Fatal hypoglycemic coma from the use of tolbutamide in elderly patients: report of two cases." J Am Geriatr Soc 15 (1967): 948-50. [PMID: 6046558]
105	Sone H, Takahashi A, Yamada N "Ibuprofen-related hypoglycemia in a patient receiving sulfonylurea." Ann Intern Med 134 (2001): 344. [PMID: 11182854]
106	Storlien LH, Thorburn AW, Smythe GA, Jenkins AB, Chisholm DJ, Kraegen EW "Effect of d-fenfluramine on basal glucose turnover and fat-feeding-induced insulin resistance in rats." Diabetes 38 (1989): 499-503. [PMID: 2647557]
107	Strathman I, Schubert EN, Cohen A, Nitzberg DM "Hypoglycemia in patients receiving disopyramide phosphate." Drug Intell Clin Pharm 17 (1983): 635-8. [PMID: 6413187]
108	Tannenbaum H, Anderson LG, Soeldner JS "Phenylbutazone-tolbutamide drug interaction." N Engl J Med 290 (1974): 344. [PMID: 4809290]
109	Tran PO, Gleason CE, Robertson RP "Inhibition of interleukin-1beta-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet beta-cell function." Diabetes 51 (2002): 1772-8. [PMID: 12031964]
110	Tremaine LM, Wilner KD, Preskorn SH "A study of the potential effect of sertraline on the pharmacokinetics and protein binding of tolbutamide." Clin Pharmacokinet 32(Suppl 1) (1997): 31-36. [PMID: 9068933]
111	Verdy M, Charbonneau L, Verdy I, Belanger R, Bolte E, Chiasson JL "Fenfluramine in the treatment of non-insulin-dependent diabetics: hypoglycemic versus anorectic effect." Int J Obes 7 (1983): 289-97. [PMID: 6629637]
112	Vuksan V, Sievenpiper JL, Koo VY, et al "American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus." Arch Intern Med 160 (2000): 1009-13. [PMID: 10761967]
113	Vuksan V, Stavro MP, Sievenpiper JL, et al "Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes." Diabetes Care 23 (2000): 1221-6. [PMID: 10977009]
114	Whitcroft IA, Thomas JM, Rawsthorne A, et al "Effects of alpha and beta adrenoceptor blocking drugs and ACE inhibitors on long term glucose and lipid control in hypertensive non-insulin dependent diabetics." Horm Metab Res Suppl 22 (1990): 42-6. [PMID: 1975246]
115	Wiederholt IC, Genco M, Foley JM "Recurrent episodes of hypoglycemia induced by propoxyphene." Neurology 17 (1967): 703-6. [PMID: 6067489]
116	Wing LM, Miners JO "Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition." Br J Clin Pharmacol 20 (1985): 482-5. [PMID: 3878154]
117	World Health Organization "WHO Public Assessment Reports (WHOPARs).".
118	Wu B, Sato T, Kiyosue T, Arita M "Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs." Cardiovasc Res 26 (1992): 1095-101. [PMID: 1291087]
119	Product Information. Berinert (complement C1 esterase inhibitor). CSL Behring, King of Prussia, PA.
120	Product Information. Ruconest (conestat alfa). Valeant Pharmaceuticals, Costa Mesa, CA.
121	Gandhi PK, Gentry WM, Bottorff MB "Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system database." Pharmacotherapy 32 (2012): 902-9. [PMID: 23033229]
122	Ben Salem C, Fathallah N, Hmouda H, Bouraoui K "Drug-induced hypoglycaemia: an update." Drug Saf 34 (2011): 21-45. [PMID: 20942513]
123	Product Information. Afrezza (insulin inhalation, rapid acting). MannKind Corporation, Valencia, CA.
124	Product Information. Humalog (insulin lispro). Lilly, Eli and Company, Indianapolis, IN.
125	Product Information. Humulin 70/30 (insulin isophane-insulin regular). Lilly, Eli and Company, Indianapolis, IN.
126	Product Information. Ryzodeg 70/30 FlexTouch (insulin aspart-insulin degludec). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
127	Product Information. Tresiba FlexTouch (insulin degludec). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
128	Vuorinen-Markkola H, Yki-Jarvinen H "Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus." Metabolism 44 (1995): 85-9. [PMID: 7854171]
129	Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
130	Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
131	Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
132	Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
133	Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
134	Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
135	Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
136	Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
137	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
138	Christ TN, Stock W, Knoebel RW "Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen." J Oncol Pharm Pract 24 (2018): 299-308. [PMID: 28355969]
139	Jenkins R, Perlin E "Severe hepatotoxicity from Escherichia coli L-asparaginase." J Natl Med Assoc 79 (1987): 775-9. [PMID: 3305969]
140	Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine" Proc (Bayl Univ Med Cent) 29 (2016): 46-7. [PMID: 26722167]
141	Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
142	Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
143	Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
144	Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
145	Burke PW, Aldoss I, Lunning MA, et.al "High-grade PEGylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles." Blood 122 (2013): 2671. [PMID: 29407583]
146	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
147	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
148	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
149	Product Information. Cinryze (complement C1 esterase inhibitor). ViroPharma Incorporated, Exton, PA.
150	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
151	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
152	Gilead Sciences, Inc "About Remdesivir.".
153	US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
154	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
155	Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
156	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence